Recently, working in the direction of biocompatible nanoparticle-based anticancer therapeutics for treatment of drug-resistant cancers, a study using plasma concentration of human serum albumin found the fraction of free drug to be 18% greater for the B isomer than the N isomer (two conformers of HSA) [103,104,105]. This evidence concerns the gene ALB and cancer.